Kirkland & Ellis advised Duality Biotherapeutics, Inc. on the transaction.Duality Biotherapeutics, Inc. (HKEx: 9606) announced its global offering and listing on the Main Board of the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
